Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma kinins in synovial exudates.

Literature DB >> 5429076

Plasma kinins in synovial exudates.

V Eisen.

Abstract

Mesh：

Substances：

Year: 1970 PMID： 5429076 PMCID： PMC2072272

Source DB: PubMed Journal: Br J Exp Pathol ISSN： 0007-1021

× No keyword cloud information.

12 in total

1. Pain-producing substance in human inflammatory exudates and plasma.

Authors: D ARMSTRONG; J B JEPSON; C A KEELE; J W STEWART
Journal: J Physiol Date: 1957-02-15 Impact factor: 5.182

2. A delayed slow contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin.

Authors: M SCHACHTER
Journal: Br J Pharmacol Chemother Date: 1956-06

3. Bradykinin and cardiovascular system: estimation of half-life.

Authors: K SAAMELI; T K ESKES
Journal: Am J Physiol Date: 1962-08

4. Protein measurement with the Folin phenol reagent.

Authors: O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal: J Biol Chem Date: 1951-11 Impact factor: 5.157

Review 5. The release and fate of vaso-active hormones in the circulation.

Authors: J R Vane
Journal: Br J Pharmacol Date: 1969-02 Impact factor: 8.739

6. A radioimmunoassay for bradykinin in plasma and synovial fluid.

Authors: R C Talamo; E Haber; K F Austen
Journal: J Lab Clin Med Date: 1969-11

7. Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category.

Authors: M K Jasani; M Katori; G P Lewis
Journal: Ann Rheum Dis Date: 1969-09 Impact factor: 19.103

8. Kininase in human polymorphonuclear leukocytes.

Authors: H Zachariae; J Malmquist; J A Oates
Journal: Life Sci Date: 1966-12 Impact factor: 5.037

9. Urates and kinin formation in synovial fluid.

Authors: V Eisen
Journal: Proc R Soc Med Date: 1966-04

10. The in vitro inactivation and formation of plasma kinins by spleen cathepsins.

Authors: L M Greenbaum; K Yamafuji
Journal: Br J Pharmacol Chemother Date: 1966-05

9 in total

Review 1. Kallikreins and kinins: mediators in inflammatory joint disease?

Authors: K Worthy; C D Figueroa; P A Dieppe; K D Bhoola
Journal: Int J Exp Pathol Date: 1990-08 Impact factor: 1.925

2. Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent.

Authors: N J Solan; P E Ward; S P Sanders; M C Towns; J M Bathon
Journal: Inflammation Date: 1998-02 Impact factor: 4.092

3. Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism.

Authors: J M Bathon; F H Chilton; W C Hubbard; M C Towns; N J Solan; D Proud
Journal: Inflammation Date: 1996-10 Impact factor: 4.092

4. Regulation of bradykinin-induced cyclic amp response by quinacrine and prostaglandin E2 and F2 alpha in human synovial fibroblasts.

Authors: J V Fahey; D S Newcombe
Journal: Inflammation Date: 1979-07 Impact factor: 4.092

5. Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.

Authors: F Bellucci; P Cucchi; C Catalani; S Giuliani; S Meini; C A Maggi
Journal: Br J Pharmacol Date: 2009-12 Impact factor: 8.739